Alzheimer’s, liver cancer, and research in China
About this episode
The episode discusses advancements in Alzheimer's disease and liver cancer research, along with the ethical challenges of new treatments.
Gavin is joined once again by Richard and Jessamy as they examine key developments in global health and science. This week's discussion features reflections on the launch of a new Lancet series on Alzheimer’s disease, highlighting advances in prevention, diagnosis, and care, as well as the ethical and practical challenges posed by emerging treatments. We also explore the global landscape of liver cancer, demographic change, the shifting centre of scientific research, and recent studies on h...
More episodes of The Lancet Voice
- Bioethics flashpoints of the next decade
- What happened when cannabis was legalised in the US?
- Health in India and global funding cuts
- Ami Baba and Martin Offringa on SPIRIT-C and CONSORT-C child and adolescent extensions
- The fallout of COP30
- Mumtaz Patel on UK NHS workforce and training issues
Explore listener stats, chart rankings, contacts and more on the The Lancet Voice podcast page.